What is Sarepta Therapeutics, Inc.'s capex?

Sarepta Therapeutics, Inc. (SRPT) reported capex of $2.08M in Q1 2026.

How has Sarepta Therapeutics, Inc.'s capex changed year-over-year?

Sarepta Therapeutics, Inc.'s capex decreased by 95.2% year-over-year, from $43.65M to $2.08M.

What is the long-term trend for Sarepta Therapeutics, Inc.'s capex?

Over 4 years (2021 to 2025), Sarepta Therapeutics, Inc.'s capex has grown at a 27.6% compound annual growth rate (CAGR), from $38.49M to $101.97M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Sarepta Therapeutics, Inc. SRPT CapEx

CapEx at other companies

PfizerPFE

$436M-22.7%

Regeneron PharmaceuticalsREGN

$230.6M+0.6%

BioMarin PharmaceuticalsBMRN

$20.92M+24.8%

PTC TherapeuticsPTCT

$1.2M-30.6%

InsmedINSM

$3.48M-65.4%

Capricor TherapeuticsCAPR

$5.12M+472%

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.82B-63.1%

Enterprise value$1.56B-67.2%

P/S0.8×—

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s capex?: Sarepta Therapeutics, Inc. (SRPT) reported capex of $2.08M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s capex changed year-over-year?: Sarepta Therapeutics, Inc.'s capex decreased by 95.2% year-over-year, from $43.65M to $2.08M.
What is the long-term trend for Sarepta Therapeutics, Inc.'s capex?: Over 4 years (2021 to 2025), Sarepta Therapeutics, Inc.'s capex has grown at a 27.6% compound annual growth rate (CAGR), from $38.49M to $101.97M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.